FluGen Initiates NIH-Funded Trial of M2SR Flu Vaccine; First Study in Adults Up to Age 85

– Study will measure immune responses to matched and drifted virus strains in older adults, a population that is most vulnerable to mortality from flu – – Topline data expected… read more →